http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1109724-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c44d7fd173ee9505022d4277e7c530ba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b39e217882fbe0bf08d9d86cefeba8a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801955c7cb2619c6940dff28f81cb9e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b9fa8d6afeb3cd5b05ede3bcb419ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f962ac1ff74a064d79a76c5dd7377e22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72618b111d23be66da5f37adb2307a8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67abf4d9fa6fb9868e541ffc540309d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcdb23c6e5f85fc38f39328d410d4822
publicationDate 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1109724-T1
titleOfInvention THIADIAZOLIDINONES AS SUSPENSIONS GSK-3
abstract The thiadiazolidine compounds of formula I <CHEM> are provided wherein R1 is an organic group having at least 8 atoms selected from C or O, not directly linked to N via a -C (O) - and comprising at least one aromatic ring , and their pharmaceutical compositions. These compounds are selective GSK-3 inhibitors and have improved bioavailability. They are useful for the treatment of GSK-3 mediated diseases, including Alzheimer's disease, type II diabetes, depression and brain damage.
priorityDate 2004-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21887071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414781203

Total number of triples: 46.